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Original article
Ambulatory blood pressure monitoring (ABPM) provides 
several distinct measures that cannot be determined by 
clinic blood pressure (BP) alone.1 These measures include 
“true” or mean BP, nocturnal BP, and 24-hour BP variabil-
ity. Additionally, several phenotypes can be defined by either 
the presence of a clinic-ambulatory hypertension mismatch 
(i.e., masked hypertension and white coat hypertension) 
or comparison of day and night BP (e.g., nondipping pat-
tern). Higher mean ambulatory BP and separately masked 
hypertension maintain strong associations with an increased 
risk for cardiovascular disease (CVD) outcomes, whereas 
white coat hypertension typically has a benign prognosis.2,3 
Recent studies have also reported associations of higher 
24-hour BP variability and, separately, abnormal diurnal BP 
patterns (e.g., nighttime BP nondipping and/or nocturnal 
hypertension) with an increased risk of CVD and all-cause 
mortality.4–6
African Americans have higher clinic BP and an increased 
risk for CVD and all-cause mortality than Whites.7,8 
Additionally, African Americans are more likely than Whites 
to have abnormal autonomic function, abnormal baroreflex 
function, and altered sodium excretion.9–11 These biologi-
cal mechanisms are implicated not only in higher mean BP, 
but also in increased BP variability and abnormal diurnal 
BP rhythm.12–14 Therefore, compared with Whites, African 
Americans may have higher mean ambulatory BP, a higher 
prevalence of masked hypertension, increased BP vari-
ability, and abnormal diurnal rhythm on ABPM. As prior 
population-based studies of ABPM have had scarce minority 
representation, there are limited data on racial differences 
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Background
Several ambulatory blood pressure monitoring (ABPM) measures have 
been associated with increased cardiovascular disease risk independ-
ent of clinic blood pressure (BP). African Americans have higher clinic 
BP compared with Whites but few data are available on racial differ-
ences in ABPM measures.
Methods
We compared ABPM measures between African American (n  =  178) 
and White (n  =  103) participants at the Year 5 Coronary Artery Risk 
Development in Young Adults study visit. BP was measured during a 
study visit and the second and third measurements were averaged. 
ABPM was conducted over the following 24 hours.
results
Mean ± SD age of participants was 29.8 ± 3.8 years and 30.8 ± 3.5 years 
for African Americans and Whites, respectively. Mean daytime systolic 
BP (SBP) was 3.90 (SD 1.18) mm Hg higher among African Americans 
compared with Whites (P  <  0.001) after age–gender adjustment and 
1.71 (SD 1.03) mm Hg higher after multivariable adjustment including 
mean clinic SBP (P  =  0.10). After multivariable adjustment including 
mean clinic SBP, nighttime SBP was 4.83 (SD 1.11) mm Hg higher among 
African Americans compared with Whites (P < 0.001). After multivariable 
adjustment, the African Americans were more likely than Whites to have 
nocturnal hypertension (prevalence ratio: 2.44, 95% CI: 0.99–6.05) and 
nondipping (prevalence ratio: 2.50, 95% CI: 1.39–4.48). The prevalence 
of masked hypertension among African Americans and Whites was 
4.4% and 2.1%, respectively, (P = 0.49) and white coat hypertension was 
3.3% and 3.9%, respectively (P = 0.99). Twenty-four hour BP variability 
on ABPM was higher among African Americans compared with Whites.
conclusions
These data suggest racial differences in several ABPM measures exist.
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in ABPM measures and the prevalence of abnormal BP 
phenotypes.
The aim of the current study was to examine racial differ-
ences in BP measures defined by 24-hour ABPM between 
Whites and African Americans. Specifically, using data from 
the Coronary Artery Risk Development in Young Adults 
(CARDIA) study, we compared mean levels of daytime 
and nighttime systolic BP (SBP) and diastolic BP (DBP) 
and 24-hour BP variability on ABPM between Whites and 
African Americans. Additionally, racial differences in the 
prevalence of sustained, masked, white coat, and nocturnal 
hypertension and BP nondipping were determined.
Methods
CARDIA is a prospective cohort study sponsored by the 
National Heart, Lung, and Blood Institute. Detailed methods 
for CARDIA have been published previously.15 In brief, the 
cohort was recruited at four field centers in the United States 
(Birmingham, AL; Chicago, IL; Minneapolis, MN; and 
Oakland, CA). CARDIA enrolled 5,115 African American 
and White men and women, aged 18–30 years, in 1985 and 
1986. Of relevance to the current analysis, ABPM was con-
ducted in participants from the Birmingham, AL field center 
at the Year 5 study visit in 1990–91. Overall, 400 of the 939 
CARDIA participants enrolled at the Birmingham center 
who attended the Year 5 study visit were randomly selected 
to participate in the ABPM substudy. The ABPM substudy 
was completed by 316 participants. The primary reason for 
nonparticipation was burden of the ABPM after the study 
visit and jobs that made ABPM difficult to complete (e.g., 
truck drivers).
data collection
Data on age, gender, and self-reported race were collected 
by questionnaire at the baseline CARDIA study visit and 
confirmed at the Year 5 study visit. Educational status and 
current smoking at the time of the Year 5 study exam were 
determined through self-report. Physical activity at the Year 
5 study visit was assessed using the interview-administered 
Physical Activity History Questionnaire.16 Physical activity 
is reported in exercise units with 300 units approximating 
the American College of Sports Medicine recommenda-
tions for the amount of exercise needed to support weight 
loss. Body mass index (BMI) was calculated based on meas-
ured height and weight from the Year 5 study visit. Blood 
was collected at the Year 5 study visit and stored at –70 °C 
until measurements were performed. Both fasting glucose 
and fasting lipid profile (triglycerides, total cholesterol, and 
high-density lipoprotein (HDL) cholesterol) were measured 
using a standard laboratory technique. The presence of dia-
betes was defined as fasting blood glucose ≥126 mg/dl or use 
of insulin and/or oral hypoglycemic agents.
clinic BP measurements
Clinic SBP and DBP were measured at the Year 5 
CARDIA examination following standardized protocols by 
trained and certified staff. Briefly, BP was measured on the 
right arm with a Hawksley random-zero sphygmomanom-
eter (W. A. Baum Co., Copiague, NY). The appropriate BP 
cuff size was determined by measuring the participant’s arm 
circumference at the midpoint between the acromion and 
olecranon. Participants were asked to sit quietly for at least 5 
minutes, in a comfortable posture, with feet flat on the floor 
prior to their BP measurement. All readings were taken in 
the seated position with the participant’s back supported and 
with their right arm positioned at heart level. Three clinic 
BP measurements were separated by at least 30 seconds and 
measurements were recorded to the nearest even number. 
For the current analysis, we calculated clinic SBP and DBP 
using the mean of the second and third BP measurements.
aBPM measurements
ABPM was conducted over a 24-hour period following the 
study visit using a Suntech Accutracker II (Suntech Medical, 
Morrisville, NC) and an appropriately sized cuff.17 SBP and 
DBP were measured every 20 minutes between 6:00 am and 
10:00 pm and every 30 minutes from 10:00 pm to 6:00 am. 
Values outside of preset limits for SBP and DBP (≥220 or 
≤80 mm Hg for SBP and ≥130 or ≤40 mm Hg for DBP) were 
rejected and repeat BP measurements were taken. In addi-
tion, a change of 50 mm Hg in systolic pressure, of 40 mm 
Hg in diastolic pressure, or of 50 mm Hg in pulse pressure 
between readings also triggered a rejection and a new read-
ing. Daytime was defined as the period between 10:00 am 
and 8:00 pm, nighttime was defined as the period between 
midnight and 06:00 am, and morning was defined as the 
period from 08:00 am to 10:00 am.18 To be eligible for the 
current study, we required participants to have 10+ valid 
daytime readings and 5+ valid nighttime readings. These 
criteria are consistent with those applied in the International 
Database of Ambulatory Blood Pressure in relation to 
Cardiovascular Outcome (IDACO), a very large interna-
tional database consisting of several prospective population-
based samples.18 Poor sleep quality during the ABPM period 
was defined by the participant reporting not being able to 
fall asleep, not being able to sleep at all, or being awakened 
five or more times.
outcome definitions
Mean SBP and DBP during daytime and nighttime, sepa-
rately, were calculated. Elevated daytime BP was defined 
as mean SBP ≥135 mm Hg or mean DBP ≥85 mm Hg and 
elevated clinic BP was defined by mean SBP ≥140 mm Hg 
or mean DBP ≥90 mm Hg.19 Sustained hypertension was 
defined as elevated daytime and clinic BP. Masked hyperten-
sion was defined as elevated daytime BP without elevated 
clinic BP and white coat hypertension was defined as elevated 
clinic BP without elevated daytime BP. Nocturnal hyperten-
sion was defined as a mean nighttime SBP ≥120 mm Hg or 
DBP ≥70 mm Hg.20 BP dipping was defined by the ratio of 
mean nighttime-to-daytime SBP.1 Nondipping pattern was 
defined as a ratio ≥0.90. Morning surge was calculated as the 
difference between the mean SBP during the morning hours 
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and nighttime trough SBP.21 Trough SBP was defined as the 
mean of three SBP measurements: the lowest nighttime SBP 
and the measurements immediately preceding and following 
this measurement.
Two measures of BP variability were calculated: day–night 
SD (SDdn) and average real variability (ARV). The SD for 
daytime measurements and, separately for nighttime meas-
urements, was calculated and the SDdn was calculated as the 
weighted mean of these SDs.22 This approach is considered 
advantageous compared with calculating a single SD over 24 
hours because it eliminates the influence of the day–night 
change in BP. ARV was calculated as the average absolute 
difference between consecutive readings over the 24-hour 
ABPM period.23 The ARV accounts for the order of BP 
measurements over the ABP monitoring period.
statistical analysis
Participant characteristics and clinic SBP, DBP, and pulse 
pressure were calculated for Whites and African Americans 
and compared using t-tests and chi-square tests, as appro-
priate. Additionally, ABPM phenotypes including mean 
daytime, nighttime, and morning SBP and DBP, SDdn and 
ARV of SBP and DBP, dipping percent, and morning surge 
were calculated by race and compared using t-tests. Racial 
differences in these phenotypes were determined after mul-
tivariable adjustment using linear regression models. Initial 
models included adjustment for age and gender (Model 1). 
Subsequent models also included adjustment for education, 
physical activity, current smoking, BMI, height, heart rate, 
diabetes, and total and HDL cholesterol (Model 2). In a third 
level of adjustment, (i) mean daytime and nighttime SBP 
were also adjusted for mean clinic SBP, (ii) mean daytime 
and nighttime DBP were also adjusted for mean clinic DBP, 
(iii) SDdn and ARV of SBP were adjusted for daytime SBP, 
and (iv) SDdn and ARV of DBP were adjusted for daytime 
DBP. For the outcomes of nighttime SBP and DBP, dipping 
percent, morning surge, and SDdn and ARV, a fourth level of 
adjustment also included poor sleep quality during ABPM.
The prevalence of sustained, masked, white coat, and noc-
turnal hypertension and BP nondipping were each calculated 
for Whites and African Americans and the prevalence ratio 
for these phenotypes in African Americans vs. Whites was 
determined using negative binomial regression models with 
adjustment as described for Models 1 and 2 above. A third 
model including additional adjustment for poor sleep qual-
ity during ABPM was also done for nocturnal hypertension 
and BP nondipping. Prevalence ratios are recommended in 
lieu of odds ratios for cross-sectional studies with common 
outcomes.24 P values <0.05 were considered statistically sig-
nificant. Analyses were conducted using SAS Version 9.3 
(SAS Institute, Cary, NC).
results
Of the 316 CARDIA participants who completed ABPM, 
281 participants (89%; 178 African Americans and 103 
Whites) had 10+ daytime BP readings and 5+ nighttime BP 
readings and were included in our analyses. Characteristics 
of participants included and not included in the current 
Table 1. Characteristics of White and African American CARDIA participants with ABPM data at the Year 5 study visit
Whites (n = 103) African Americans (n = 178) P value
Age, years 30.8 (3.5) 29.8 (3.8) 0.02
Women, % 48.5 56.7 0.18
Formal education, years 14.3 (2.4) 13.8 (2.0) 0.04
Physical activity, exercise units 302.1 (237.2) 326.0 (283.4) 0.45
Current smoking, % 29.1 28.1 0.19
Body mass index, kg/m2 25.7 (5.4) 27.0 (5.2) 0.046
Height, cm 170.4 (8.4) 170.0 (9.9) 0.73
Heart rate, beats per minute 79.1 (10.0) 82.1 (9.9) 0.02
Diabetes, % 1.9 2.8 0.65
Total cholesterol, mg/dl 184.1 (33.3) 176.4 (33.2) 0.06
HDL cholesterol, mg/dl 47.1 (12.8) 53.0 (14.1) <0.001
Clinic blood pressure
 Systolic blood pressure, mm Hg 107.3 (10.5) 110.2 (10.6) 0.03
 Diastolic blood pressure, mm Hg 71.6 (10.6) 74.0 (9.3) 0.06
 Pulse pressure, mm Hg 35.3 (4.4) 34.8 (4.2) 0.27
Taking antihypertensive medication, % 0.0 1.7 0.30
Poor sleep quality during ABPM, % 20.4 13.5 0.13
Numbers are mean (SD) or percentage.
Abbreviations: ABPM, ambulatory blood pressure monitoring; CARDIA, Coronary Artery Risk Development in Young Adults; HDL, high-
density lipoprotein.
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study are presented in Supplementary Table  1. The mean 
age of Whites and African Americans was 30.8 (SD 3.5) and 
29.8 (SD 3.8) years, respectively (Table 1). Compared with 
Whites, African Americans had a lower mean level of edu-
cation and higher mean BMI, heart rate, and HDL choles-
terol. Additionally, compared with their White counterparts, 
African Americans had higher mean clinic SBP. No Whites 
and 1.7% of African Americans (n = 3) were taking antihy-
pertensive medication.
Mean daytime SBP was higher among African Americans 
compared with Whites (Table 2). This association was pre-
sent after age–gender adjustment and further adjustment for 
education, physical activity, current smoking, BMI, height, 
heart rate, diabetes, and total and HDL cholesterol. After 
adjustment for clinic SBP, daytime SBP was 1.71 (SD 1.03) 
mm Hg higher among African Americans compared with 
Whites (P = 0.10). African American–White differences in 
daytime DBP were not statistically significant before or after 
multivariable adjustment. Nighttime SBP and DBP were 
higher among African Americans compared with Whites. 
After multivariable adjustment including clinic BP and poor 
sleep quality during ABPM, nighttime SBP and DBP were 
4.83 (SD 1.11) mm Hg and 2.29 (SD 0.87) higher, respec-
tively, among African Americans compared with Whites.
Among African Americans and Whites, the prevalence 
of sustained hypertension was 3.4% and 1.9%, respectively, 
Table 2. Mean daytime and nighttime systolic and diastolic blood pressure for White and African American CARDIA participants at the Year 
5 study visit
Whites (n = 103) African Americans (n = 178) P value
Daytime
 Systolic blood pressure, mm Hg
  Mean (SD) 116.3 (9.7) 119.6 (10.5) 0.01
 Adjusted difference
  Model 1 0 (ref.) 3.90 (1.18) 0.001
  Model 2 0 (ref.) 3.09 (1.23) 0.01
  Model 3a 0 (ref.) 1.71 (1.03) 0.10
 Diastolic blood pressure, mm Hg
  Mean (SD) 69.4 (6.8) 70.9 (7.0) 0.09
 Adjusted difference
  Model 1 0 (ref.) 2.07 (0.85) 0.02
  Model 2 0 (ref.) 1.41 (0.87) 0.11
  Model 3b 0 (ref.) 0.44 (0.77) 0.56
Nighttime
 Systolic blood pressure, mm Hg
  Mean (SD) 101.7 (10.0) 108.1 (11.0) <0.001
 Adjusted difference
  Model 1 0 (ref.) 7.11 (1.23) <0.001
  Model 2 0 (ref.) 5.97 (1.24) <0.001
  Model 3a 0 (ref.) 4.79 (1.11) <0.001
  Model 3a + poor sleep qualitya 0 (ref.) 4.83 (1.11) <0.001
 Diastolic blood pressure, mm Hg
  Mean (SD) 56.9 (6.7) 60.2 (7.8) <0.001
 Adjusted difference
  Model 1 0 (ref.) 3.86 (0.90) <0.001
  Model 2a 0 (ref.) 3.19 (0.94) <0.001
  Model 3b 0 (ref.) 2.32 (0.86) 0.01
  Model 3b + poor sleep qualitya 0 (ref.) 2.29 (0.87) 0.01
Numbers are mean (SD) or percentage. Model 1 includes adjustment for age and gender. Model 2 includes adjustment for age, gender, edu-
cation, physical activity, current smoking, body mass index, height, heart rate, diabetes mellitus, total cholesterol, and high-density lipoprotein 
cholesterol. Model 3a includes variables in Model 2 with additional adjustment for mean clinic systolic blood pressure. Model 3b includes vari-
ables in Model 2 with additional adjustment for mean clinic diastolic blood pressure.
Abbreviation: CARDIA, Coronary Artery Risk Development in Young Adults.
aPoor sleep quality during ambulatory blood pressure monitoring.
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and masked hypertension was 4.4% and 2.1%, respectively 
(Table  3). The prevalence ratios of sustained and masked 
hypertension for African Americans compared with Whites 
were not statistically significant after multivariable adjust-
ment. The prevalence of white coat hypertension was 3.3% 
for African Americans and 3.9% among Whites and differ-
ences were not statistically significant before or after mul-
tivariable adjustment. Overall, 16.9% of African Americans 
and 8.7% of Whites had nocturnal hypertension (P = 0.06). 
The African American–White prevalence ratio for nocturnal 
hypertension was 2.52 (95% CI: 1.12–5.68) after age–gen-
der adjustment and 2.44 (95% CI: 0.99–6.05) after further 
adjustment for education, physical activity, current smoking, 
BMI, height, heart rate, diabetes, total and HDL cholesterol, 
and poor sleep quality during ABPM.
The nighttime dip in SBP (i.e., relative decline in SBP) on 
ABPM was 0.90 (SD 0.06) in African Americans compared 
with 0.87 (SD 0.06) in Whites (Table 4; P < 0.001). African 
Americans had less dipping than Whites with 48.3% of 
African Americans and 27.2% of Whites being nondippers 
(P < 0.001). African Americans were more likely than Whites 
to be nondippers after age–gender and multivariable adjust-
ment. Morning surge was smaller in African Americans 
(15.2 (SD 11.8) mm Hg) compared with Whites (18.4 (SD 
10.0) mm Hg; P = 0.02). After age–gender and multivariable 
adjustment, the difference in morning surge was not statisti-
cally significant.
SDdn of SBP was higher among African Americans com-
pared with Whites (Table  5; P  <  0.001). This association 
remained statistically significant after initial adjustment 
(Models 1 and 2) but was no longer statistically significant 
after further adjustment for daytime SBP. ARV of SBP was 
higher for Africans Americans compared with Whites before 
and after multivariable adjustment. Additionally, SDdn and 
ARV of DBP were higher in African Americans compared 
with Whites before and after multivariable adjustment.
discussion
In the present study, levels of several ABPM measure-
ments and prevalence of abnormal phenotypes were higher 
among African American compared with White young 
adults. Mean nighttime SBP and measures of BP variability 
were each higher, and nocturnal hypertension and nondip-
ping were more common among African Americans com-
pared with Whites. Although not statistically significant, 
African Americans had higher daytime SBP and were two 
times more likely than Whites to have masked hypertension. 
Table 3. Prevalence and prevalence ratios for sustained, masked, white coat, and nocturnal hypertension comparing African American and 
White CARDIA participants
White (n = 103) African American (n = 178) P value
Sustained hypertension
 Prevalence, % 1.9 3.4 0.72
 Prevalence ratio
  Model 1 1 (ref.) 2.21 (0.43,11.45) 0.35
  Model 2 1 (ref.) 3.19 (0.45, 22.82) 0.25
Masked hypertension
 Prevalence, % 2.1 4.4 0.49
 Prevalence ratio
  Model 1 1 (ref.) 2.15 (0.43, 10.78) 0.35
  Model 2 1 (ref.) 1.48 (0.25, 8.75) 0.67
White coat hypertension
 Prevalence, % 3.9 3.3 0.99
 Prevalence ratio
  Model 1 1 (ref.) 1.11 (0.30, 4.16) 0.88
  Model 2 1 (ref.) 1.55 (0.31, 7.73) 0.59
Nocturnal hypertension
 Prevalence, % 8.7 16.9 0.06
 Prevalence ratio
  Model 1 1 (ref.) 2.52 (1.12, 5.68) 0.03
  Model 2 1 (ref.) 2.39 (0.97, 5.88) 0.06
  Model 2 + poor sleep qualitya 1 (ref.) 2.44 (0.99, 6.05) 0.054
Model 1 includes adjustment for age and gender. Model 2 includes additional adjustment for education, physical activity, current smoking, 
body mass index, height, heart rate, diabetes mellitus, total cholesterol, and high-density lipoprotein cholesterol.
Abbreviation: CARDIA, Coronary Artery Risk Development in Young Adults.
aPoor sleep quality during ambulatory blood pressure monitoring.
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In contrast, morning surge was smaller among African 
Americans. The data from the current study suggest that 
substantial racial differences on ABPM, particularly night-
time SBP, nocturnal hypertension, and BP variability, may 
exist between African Americans and Whites.
Several years ago, the concept of “true” or mean BP was 
introduced and conceptualized as the mean level of BP over 
a long period of time.25 While clinic BP is often regarded 
as a proxy for an individual’s true BP, several studies have 
found substantial discrepancies between clinic BP and true 
BP with only a moderate correlation existing between mean 
clinic BP and daytime BP (r < 0.50).26 Importantly, several 
studies have found mean BP on ABPM maintains a strong 
association with CVD events independent of clinic BP.27 In 
the current analysis, African Americans had higher clinic BP 
compared with Whites. Although not statistically significant 
after adjustment for clinic BP, daytime SBP was 1.71 mm Hg 
higher in African Americans than Whites.
Mean nighttime SBP and DBP were significantly higher 
among African Americans compared with Whites even after 
full multivariable adjustment including clinic BP. These data 
are consistent with prior studies that have reported higher 
SBP and DBP levels and a higher prevalence of nocturnal 
hypertension and nondipping for African Americans com-
pared with Whites.28,29 In a meta-analysis investigating 
racial differences in nighttime BP, expressed using stand-
ardized mean differences, African Americans had higher 
mean nighttime SBP and DBP compared with Whites.30 
This meta-analysis also reported less dipping among African 
Americans compared with Whites. However, few studies 
included in the meta-analysis were population-based, limit-
ing the generalizability of the findings. A prior study reported 
a higher prevalence of nondipping among Black Hispanics 
(69.4%) compared with White Hispanics (52.7%).31 The cur-
rent study extends prior research with a larger sample size 
and examination of ABPM measures in a population-based 
sample.
Among the different ABPM measures we studied, morn-
ing surge was the only one that was smaller for African 
Americans compared with Whites. The smaller morn-
ing surge among African Americans may be a direct result 
from the substantially higher nighttime BP among African 
Americans. Also, compared with prior studies, the magni-
tude of the morning surge was small for both Whites and 
African Americans.21,32 In a prior analysis of IDACO, the risk 
for CVD was increased only for participants with morning 
surge ≥37 mm Hg vs. <37 mm Hg. The relatively low morn-
ing surge in the current analysis may reflect the young age of 
participants. Small artery disease, endothelial dysfunction, 
arterial stiffness, and orthostatic hypertension are each more 
common at older age and have been associated with higher 
morning surge.33,34 Whether middle-aged and older African 
Americans have higher morning surge than Whites should 
be evaluated in future studies.
Beyond diurnal patterns in BP, BP variability across a 
24-hour period has emerged as an ABPM measure with 
Table 4. Dipping and nondipping pattern and morning surge comparing African American and White CARDIA participants
White (n = 103) African American (n = 178) P value
Dipping, %
 Mean (SD) 0.87 (0.06) 0.90 (0.06) <0.001
 Adjusted difference
  Model 1 0 (ref.) 0.03 (0.01) <0.001
  Model 2 0 (ref.) 0.03 (0.01) <0.001
  Model 2 + poor sleep qualitya 0 (ref.) 0.03 (0.01) <0.001
Nondipping pattern
 Prevalence 27.2 48.3 <0.001
 Prevalence ratio
  Model 1 1 (ref.) 2.70 (1.58, 4.62) <0.001
  Model 2 1 (ref.) 2.52 (1.40, 4.51) 0.002
  Model 2 + poor sleep qualitya 0 (ref.) 2.50 (1.39 – 4.48) 0.002
Morning surge, mm Hg
 Mean (SD) 18.4 (10.0) 15.2 (11.8) 0.02
 Adjusted difference
  Model 1 0 (ref.) -2.26 (1.40) 0.06
  Model 2 0 (ref.) -2.26 (1.52) 0.14
  Model 2 + poor sleep qualitya 0 (ref.) -2.40 (1.52) 0.12
Model 1 includes adjustment for age and gender. Model 2 includes additional adjustment for education, physical activity, current smoking, 
body mass index, height, heart rate, diabetes mellitus, total cholesterol and high-density lipoprotein cholesterol.
Abbreviation: CARDIA, Coronary Artery Risk Development in Young Adults.
aPoor sleep quality during ambulatory blood pressure monitoring.
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prognostic importance for CVD risk.4 In a meta-analysis of 
8,938 participants from 11 studies, ARV of SBP was associ-
ated with all-cause and cardiovascular mortality, CVD inci-
dence, and stroke but not cardiac or coronary events.4 Also, 
SDdn was associated with all-cause mortality. However, this 
meta-analysis did not have any data on African Americans. 
In the current study, African Americans had a significantly 
higher ARV of SBP and SDdn and ARV of DBP compared 
with Whites even after multivariable adjustment.
It has been hypothesized that a higher prevalence of sev-
eral abnormal ABPM measures among African Americans 
compared with Whites may explain the excess CVD risk they 
experience.32 Nondipping patterns, nocturnal hypertension, 
and higher BP variability, each of which are associated with 
increased CVD risk, were higher among African Americans 
compared with Whites.4–6 ABPM was only performed in a 
subset of CARDIA participants, precluding assessing their 
association with CVD outcomes. Future studies are needed 
to better understand whether the racial differences in ABPM 
phenotypes identified in the current study contribute to the 
higher risk for CVD experienced by African Americans 
compared with Whites.
There are several potential mechanisms underlying the 
higher levels of ambulatory BP measures and prevalence 
of abnormal ABPM phenotypes in African Americans 
compared with Whites. Sodium sensitivity, sleep apnea, 
poor sleep quality, and socioeconomic factors have 
each been associated with abnormal ABPM phenotypes 
and are more common in African Americans compared 
with Whites. Additionally, African Americans are more 
likely than Whites to have abnormal autonomic func-
tion, abnormal baroreflex function, and altered sodium 
Table 5. Ambulatory blood pressure variability for African American and White CARDIA participants
Whites (n = 103) African Americans (n = 178) P value
Systolic blood pressure
 Day–night SD, mm Hg
  Mean, mm Hg 9.9 (2.0) 10.9 (2.7) <0.001
  Model 1 0 (ref.) 1.12 (0.29) <0.001
  Model 2 0 (ref.) 0.73 (0.31) 0.02
  Model 3a 0 (ref.) 0.53 (0.30) 0.08
  Model 3a + poor sleep qualitya 0 (ref.) 0.55 (0.30) 0.07
 Average real variability, mm Hg
  Mean, mm Hg 9.0 (2.0) 10.5 (2.9) <0.001
  Model 1 0 (ref.) 1.58 (0.32) <0.001
  Model 2 0 (ref.) 1.29 (0.34) <0.001
  Model 3a 0 (ref.) 1.14 (0.34) <0.001
  Model 3a + poor sleep qualitya 0 (ref.) 1.16 (0.34) <0.001
Diastolic blood pressure
 Day–night SD, mm Hg
  Mean, mm Hg 9.3 (1.8) 10.5 (2.2) <0.001
  Model 1 0 (ref.) 1.19 (0.26) <0.001
  Model 2 0 (ref.) 0.91 (0.27) <0.001
  Model 3b 0 (ref.) 0.80 (0.26) 0.003
  Model 3b + poor sleep qualitya 0 (ref.) 0.80 (0.26) 0.003
 Average real variability, mm Hg
  Mean, mm Hg 8.5 (2.1) 10.1 (3.1) <0.001
  Model 1 0 (ref.) 1.65 (0.35) <0.001
  Model 2 0 (ref.) 1.34 (0.37) <0.001
  Model 3b 0 (ref.) 1.24 (0.37) <0.001
  Model 3b + poor sleep qualitya 0 (ref.) 1.23 (0.37) <0.001
Model 1 includes adjustment for age and gender. Model 2 includes additional adjustment for education, physical activity, current smoking, 
body mass index, height, heart rate, diabetes mellitus, total cholesterol and high-density lipoprotein cholesterol. Model 3a includes variables in 
Model 2 with additional adjustment for mean systolic blood pressure on daytime ambulatory blood pressure monitoring. Model 3b includes vari-
ables in Model 2 with additional adjustment for mean diastolic blood pressure on daytime ambulatory blood pressure monitoring.
Abbreviation: CARDIA, Coronary Artery Risk Development in Young Adults.
aPoor sleep quality during ambulatory blood pressure monitoring.
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excretion.9,10,35–37 Also, insulin resistance was reported 
to modify the association between the 24-hour sodium/
potassium ratio and several ABP measures, including 
nocturnal BP, in a study of individuals of black African 
descent.38 BP on ABPM may be adversely affected by psy-
chological factors including higher levels of stress, anxiety, 
and discrimination which are experienced disproportion-
ally by African Americans. The association between psy-
chological factors and ABP measures may be cyclical. In 
a prior study, being labeled as hypertensive was associ-
ated with greater depressive symptoms and poorer mental 
health among African Americans but no association was 
present in Whites.39 In a study by Spruill et al.,28 not being 
married and having less education explained 36% of the 
African American–White difference in dipping. Future 
studies, with larger sample sizes, are needed to determine 
the explanatory factors underlying racial differences in 
abnormal ABPM phenotypes.
Strengths of the CARDIA study include the large pop-
ulation-based sample of African Americans and Whites, 
collection of ABPM following a standardized protocol, and 
extensive data collection that allowed us to adjust for sev-
eral potential confounders. Additionally, the current anal-
ysis included African American and White participants 
aged 23–35 years at the time of their ABPM. Hypertension 
has its origins in childhood and young adulthood and 
we were able to examine differences in ABPM between 
African Americans and Whites prior to the development 
of hypertension or vascular changes such as endothelial 
dysfunction or arterial stiffness, consistent with the onset 
of hypertension. Despite the strengths of the study, the cur-
rent results need to be interpreted in the context of known 
and potential limitations. Only one ABPM was available 
and the reproducibility of some measures is modest.40,41 
Although CARDIA enrolled several thousand participants, 
a subsample was invited to complete the ABPM and data 
were available for only 281 participants at one site. Possibly 
due to the modest sample size of participants with ABPM 
data, several results were not statistically significant. Also, 
given the modest sample size, we were not able to evalu-
ate factors explaining the racial differences in the ABPM 
phenotypes.
In conclusion, in a young adult population-based sam-
ple, compared with Whites, African Americans were more 
likely to have several abnormal ABPM measures and phe-
notypes that are associated with an increased CVD risk and 
mortality. Nighttime SBP and DBP, nocturnal hyperten-
sion, nondipping, and BP variability were each higher or 
more prevalent among African Americans. Larger popu-
lation-based studies are needed to confirm our results and 
investigate whether abnormal ABPM phenotypes explain 
the higher risk for CVD among African Americans com-
pared with Whites.
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